Skip to main content
Erschienen in: neurogenetics 4/2010

01.10.2010 | SHORT COMMUNICATION

GJB1/Connexin 32 whole gene deletions in patients with X-linked Charcot–Marie–Tooth disease

verfasst von: Claudia Gonzaga-Jauregui, Feng Zhang, Charles F. Towne, Sat Dev Batish, James R. Lupski

Erschienen in: Neurogenetics | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

The X-linked form of Charcot–Marie–Tooth disease (CMTX) is the second most common form of this genetically heterogeneous inherited peripheral neuropathy. CMT1X is caused by mutations in the GJB1 gene. Most of the mutations causative for CMT1X are missense mutations. In addition, a few disease causative nonsense mutations and frameshift deletions that lead to truncated forms of the protein have also been reported to be associated with CMT1X. Previously, there have been reports of patients with deletions of the coding sequence of GJB1; however, the size and breakpoints of these deletions were not assessed. Here, we report five patients with deletions that range in size from 12.2 to 48.3 kb and that completely eliminate the entire coding sequence of the GJB1 gene, resulting in a null allele for this locus. Analyses of the breakpoints of these deletions showed that they are nonrecurrent and that they can be generated by different mechanisms. In addition to PMP22, GJB1 is the second CMT gene for which both point mutations and genomic rearrangements can cause a neuropathy phenotype, stressing the importance of CMT as a genomic disorder.
Literatur
1.
Zurück zum Zitat England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ (2009) Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 72:185–192CrossRefPubMed England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ (2009) Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 72:185–192CrossRefPubMed
2.
Zurück zum Zitat Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol 8:654–667CrossRefPubMed Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol 8:654–667CrossRefPubMed
3.
Zurück zum Zitat Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI (1991) DNA duplication associated with Charcot–Marie–Tooth disease type 1A. Cell 66:219–232CrossRefPubMed Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI (1991) DNA duplication associated with Charcot–Marie–Tooth disease type 1A. Cell 66:219–232CrossRefPubMed
4.
Zurück zum Zitat Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogenduk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA, Van Broeckhoven C (1991) Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscul Disord 1:93–97CrossRefPubMed Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogenduk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA, Van Broeckhoven C (1991) Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscul Disord 1:93–97CrossRefPubMed
5.
Zurück zum Zitat Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel PI, Lupski JR (1994) Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 3:223–228CrossRefPubMed Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel PI, Lupski JR (1994) Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 3:223–228CrossRefPubMed
6.
Zurück zum Zitat Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143–151CrossRefPubMed Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143–151CrossRefPubMed
7.
Zurück zum Zitat Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH (1993) Connexin mutations in X-linked Charcot–Marie–Tooth disease. Science 262:2039–2042CrossRefPubMed Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH (1993) Connexin mutations in X-linked Charcot–Marie–Tooth disease. Science 262:2039–2042CrossRefPubMed
8.
Zurück zum Zitat Söhl G, Gillen C, Bosse F, Gleichmann M, Muller H, Willecke K (1996) A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur J Cell Biol 69:267–275PubMed Söhl G, Gillen C, Bosse F, Gleichmann M, Muller H, Willecke K (1996) A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur J Cell Biol 69:267–275PubMed
9.
Zurück zum Zitat Kleopa K, Scherer S (2006) Molecular genetics of X-linked Charcot–Marie–Tooth disease. Neuromolecular Med 8:107–122CrossRefPubMed Kleopa K, Scherer S (2006) Molecular genetics of X-linked Charcot–Marie–Tooth disease. Neuromolecular Med 8:107–122CrossRefPubMed
10.
Zurück zum Zitat Ressot C, Gomes D, Dautigny A, Pham-Dinh D, Bruzzone R (1998) Connexin32 mutations associated with X-linked Charcot–Marie–Tooth disease show two distinct behaviors: loss of function and altered gating properties. J Neurosci 18:4063–4075PubMed Ressot C, Gomes D, Dautigny A, Pham-Dinh D, Bruzzone R (1998) Connexin32 mutations associated with X-linked Charcot–Marie–Tooth disease show two distinct behaviors: loss of function and altered gating properties. J Neurosci 18:4063–4075PubMed
11.
Zurück zum Zitat Shy ME, Siskind C, Swan ER, Krajewski KM, Doherty T, Fuerst DR, Ainsworth PJ, Lewis RA, Scherer SS, Hahn AF (2007) CMT1X phenotypes represent loss of GJB1 gene function. Neurology 68:849–855CrossRefPubMed Shy ME, Siskind C, Swan ER, Krajewski KM, Doherty T, Fuerst DR, Ainsworth PJ, Lewis RA, Scherer SS, Hahn AF (2007) CMT1X phenotypes represent loss of GJB1 gene function. Neurology 68:849–855CrossRefPubMed
12.
Zurück zum Zitat Ainsworth PJ, Bolton CF, Murphy BC, Stuart JA, Hahn AF (1998) Genotype/phenotype correlation in affected individuals of a family with a deletion of the entire coding sequence of the connexin 32 gene. Hum Genet 103:242–244CrossRefPubMed Ainsworth PJ, Bolton CF, Murphy BC, Stuart JA, Hahn AF (1998) Genotype/phenotype correlation in affected individuals of a family with a deletion of the entire coding sequence of the connexin 32 gene. Hum Genet 103:242–244CrossRefPubMed
13.
Zurück zum Zitat Lin C, Numakura C, Ikegami T, Shizuka M, Shoji M, Nicholson G, Hayasaka K (1999) Deletion and nonsense mutations of the connexin 32 gene associated with Charcot–Marie–Tooth disease. Tohoku J Exp Med 188:239–244CrossRefPubMed Lin C, Numakura C, Ikegami T, Shizuka M, Shoji M, Nicholson G, Hayasaka K (1999) Deletion and nonsense mutations of the connexin 32 gene associated with Charcot–Marie–Tooth disease. Tohoku J Exp Med 188:239–244CrossRefPubMed
14.
Zurück zum Zitat Nakagawa M, Takashima H, Umehara F, Arimura K, Miyashita F, Takenouchi N, Matsuyama W, Osame M (2001) Clinical phenotype in X-linked Charcot–Marie–Tooth disease with an entire deletion of the connexin 32 coding sequence. J Neurol Sci 185:31–37CrossRefPubMed Nakagawa M, Takashima H, Umehara F, Arimura K, Miyashita F, Takenouchi N, Matsuyama W, Osame M (2001) Clinical phenotype in X-linked Charcot–Marie–Tooth disease with an entire deletion of the connexin 32 coding sequence. J Neurol Sci 185:31–37CrossRefPubMed
15.
Zurück zum Zitat Hahn AF, Ainsworth PJ, Naus CCG, Mao J, Bolton CF (2000) Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle Nerve 23:S39–S48CrossRef Hahn AF, Ainsworth PJ, Naus CCG, Mao J, Bolton CF (2000) Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle Nerve 23:S39–S48CrossRef
16.
Zurück zum Zitat Takashima H, Nakagawa M, Umehara F, Hirata K, Suehara M, Mayumi H, Yoshishige K, Matsuyama W, Saito M, Jonosono M, Arimura K, Osame M (2003) Gap junction protein beta 1 (GJB1) mutations and central nervous system symptoms in X-linked Charcot–Marie–Tooth disease. Acta Neurol Scand 107:31–37CrossRefPubMed Takashima H, Nakagawa M, Umehara F, Hirata K, Suehara M, Mayumi H, Yoshishige K, Matsuyama W, Saito M, Jonosono M, Arimura K, Osame M (2003) Gap junction protein beta 1 (GJB1) mutations and central nervous system symptoms in X-linked Charcot–Marie–Tooth disease. Acta Neurol Scand 107:31–37CrossRefPubMed
17.
Zurück zum Zitat Lee JA, Carvalho CMB, Lupski JR (2007) A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131:1235–1247CrossRefPubMed Lee JA, Carvalho CMB, Lupski JR (2007) A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131:1235–1247CrossRefPubMed
18.
Zurück zum Zitat Sen SK, Han K, Wang J, Lee J, Wang H, Callinan PA, Dyer M, Cordaux R, Liang P, Batzer MA (2006) Human genomic deletions mediated by recombination between Alu elements. 79:41-53. Sen SK, Han K, Wang J, Lee J, Wang H, Callinan PA, Dyer M, Cordaux R, Liang P, Batzer MA (2006) Human genomic deletions mediated by recombination between Alu elements. 79:41-53.
19.
20.
Zurück zum Zitat Gu W, Zhang F, Lupski J (2008) Mechanisms for human genomic rearrangements. Patho Genetics 1:4PubMed Gu W, Zhang F, Lupski J (2008) Mechanisms for human genomic rearrangements. Patho Genetics 1:4PubMed
21.
Zurück zum Zitat Zhang F, Carvalho CMB, Lupski JR (2009) Complex human chromosomal and genomic rearrangements. Trends Genet 25:298–307CrossRefPubMed Zhang F, Carvalho CMB, Lupski JR (2009) Complex human chromosomal and genomic rearrangements. Trends Genet 25:298–307CrossRefPubMed
22.
Zurück zum Zitat Hastings PJ, Ira G, Lupski JR (2009) A Microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5:e1000327CrossRefPubMed Hastings PJ, Ira G, Lupski JR (2009) A Microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5:e1000327CrossRefPubMed
23.
Zurück zum Zitat Zhang F, Khajavi M, Connolly AM, Towne CF, Batish SD, Lupski JR (2009) The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet 41:849–853CrossRefPubMed Zhang F, Khajavi M, Connolly AM, Towne CF, Batish SD, Lupski JR (2009) The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet 41:849–853CrossRefPubMed
24.
Zurück zum Zitat Carvalho CMB, Zhang F, Liu P, Patel A, Sahoo T, Bacino CA, Shaw C, Peacock S, Pursley A, Tavyev YJ, Ramocki MB, Nawara M, Obersztyn E, Vianna-Morgante AM, Stankiewicz P, Zoghbi HY, Cheung SW, Lupski JR (2009) Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching. Hum Mol Genet 18:2188–2203CrossRefPubMed Carvalho CMB, Zhang F, Liu P, Patel A, Sahoo T, Bacino CA, Shaw C, Peacock S, Pursley A, Tavyev YJ, Ramocki MB, Nawara M, Obersztyn E, Vianna-Morgante AM, Stankiewicz P, Zoghbi HY, Cheung SW, Lupski JR (2009) Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching. Hum Mol Genet 18:2188–2203CrossRefPubMed
25.
Zurück zum Zitat Scherer SS, Xu Y-T, Nelles E, Fischbeck KH, Willecke K, Bone LJ (1998) Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 24:8–20CrossRefPubMed Scherer SS, Xu Y-T, Nelles E, Fischbeck KH, Willecke K, Bone LJ (1998) Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 24:8–20CrossRefPubMed
26.
Zurück zum Zitat Scherer SS, Xu Y-T, Messing A, Willecke K, Fischbeck KH, Jeng LJB (2005) Transgenic expression of human connexin32 in myelinating schwann cells prevents demyelination in connexin32-null mice. J Neurosci 25:1550–1559CrossRefPubMed Scherer SS, Xu Y-T, Messing A, Willecke K, Fischbeck KH, Jeng LJB (2005) Transgenic expression of human connexin32 in myelinating schwann cells prevents demyelination in connexin32-null mice. J Neurosci 25:1550–1559CrossRefPubMed
Metadaten
Titel
GJB1/Connexin 32 whole gene deletions in patients with X-linked Charcot–Marie–Tooth disease
verfasst von
Claudia Gonzaga-Jauregui
Feng Zhang
Charles F. Towne
Sat Dev Batish
James R. Lupski
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Neurogenetics / Ausgabe 4/2010
Print ISSN: 1364-6745
Elektronische ISSN: 1364-6753
DOI
https://doi.org/10.1007/s10048-010-0247-4

Weitere Artikel der Ausgabe 4/2010

neurogenetics 4/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.